NEULAND LABS Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEULAND LABS Quarterly Results    (NELB)

Here are the latest quarterly results of NEULAND LABS. For more details, see the NEULAND LABS financial fact sheet and NEULAND LABS share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

NEULAND LABS Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-18
3
Dec-18
3
Mar-19
3
Jun-19
3
Sep-19
3
Dec-19
3
Mar-20
3
Jun-20
8-Qtr Chart
Click to enlarge
Net Sales Rs m1,6871,7151,7271,8101,8622,0361,9192,054 
Other income Rs m64135610187 
Turnover Rs m1,6941,7191,7401,8151,8682,0461,9362,061 
Expenses Rs m1,5411,5561,5431,6241,6141,7561,6191,717 
Gross profit Rs m146158184186248281300337 
Depreciation Rs m5974697683787689 
Interest Rs m4130474048577154 
Profit before tax Rs m53598175123156171202 
Tax Rs m9131419384526451 
Profit after tax Rs m4446675686110-94151 
Gross profit margin %8.79.210.710.313.313.815.616.4 
Effective tax rate %16.922.016.825.230.529.1154.825.5 
Net profit margin %2.62.73.93.14.65.4-4.97.3 
Diluted EPS Rs 3.4 3.6 5.2 4.4 6.7 8.6 -7.3 11.7  
Diluted EPS (TTM) Rs NA NA NA 16.6 19.9 24.9 12.4 19.7  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   WOCKHARDT  TORRENT PHARMA  ORCHID PHARMA  ALEMBIC PHARMA  SUVEN LIFESCIENCES  

Compare NEULAND LABS With:   WOCKHARDT  TORRENT PHARMA  ORCHID PHARMA  ALEMBIC PHARMA  SUVEN LIFESCIENCES  

Compare NEULAND LABS With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Share Markets Open Higher; HDFC & IndusInd Bank Top Gainers(09:30 am)

Asian stock markets are trading on a positive note today. The Hang Seng is trading up by 0.5% and the Nikkei is trading up by 0.3%.

Views on news

NEULAND LABS 2019-20 Annual Report Analysis (Annual Result Update)

Sep 2, 2020 | Updated on Sep 2, 2020

Here's an analysis of the annual report of NEULAND LABS for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of NEULAND LABS. Also includes updates on the valuation of NEULAND LABS.

More Views on News

Most Popular

My Latest Stock Recommendation (Fast Profits Daily)

Oct 9, 2020

How I picked an exciting stock using trends from both the commodity and equity markets.

The 'Seedhi Baat, No Bakwaas' View on ITC (Profit Hunter)

Oct 12, 2020

Is ITC an investment or a speculation at current levels?

One of the Best Investment Opportunities in the Market Right Now (Fast Profits Daily)

Oct 16, 2020

The one sector that you should be looking at to make good profits.

The Inflection Point for Defence Stocks is Getting Closer (Profit Hunter)

Oct 9, 2020

Few Indian defence companies could use their engineering capabilities to eventually become global leaders.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

NEULAND LABS SHARE PRICE


Oct 21, 2020 10:16 AM

TRACK NEULAND LABS

  • Track your investment in NEULAND LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NEULAND LABS

NEULAND LABS - STRIDES PHARMA SCIENCE COMPARISON

COMPARE NEULAND LABS WITH

MARKET STATS